Literature DB >> 31327743

Midterm outcome of pharmacomechanical catheter-directed thrombolysis combined with stenting for treatment of iliac vein compression syndrome with acute iliofemoral deep venous thrombosis.

Chuli Jiang1, Yu Zhao1, Xuehu Wang1, Hong Liu1, Tze-Woei Tan2, Fenghe Li3.   

Abstract

OBJECTIVE: This study assessed the effectiveness and safety of percutaneous mechanical thrombectomy and catheter-directed thrombolysis combined with stent placement in the management of iliac vein compression syndrome with acute iliofemoral deep venous thrombosis (DVT).
METHODS: From December 2014 to April 2016, there were 46 patients with DVT who underwent percutaneous mechanical thrombectomy and catheter-directed thrombolysis and stenting for acute proximal DVT with computed tomography-verified iliofemoral stenosis. The Venous Registry Index was used for evaluating the degree of patency after pharmacomechanical thrombolysis; the prevalence of post-thrombotic syndrome (PTS) in the follow-up was assessed according to the Villalta scale. For up to 24 months, conditions of the patients were assessed using periodic duplex ultrasound scans.
RESULTS: For all patients, the technical success rate was 100%; no major bleeding or 30-day mortality was observed. Overall, the 6-, 12-, and 24-month primary patency rates were 97.8%, 95.7%, and 91.1%, respectively. There was a significant reduction in Venous Registry Index (9.82 ± 1.74 to 1.15 ± 1.02; P < .05) after the procedure. According to the Villalta score, only one patient developed mild PTS and none developed severe PTS. Symptomatic pulmonary embolism was not observed during the hospitalization. The mean hospital stay was 6.5 ± 1.7 days.
CONCLUSIONS: This technique provides a safe and effective treatment option for patients with acute proximal DVT caused by vein compression syndrome.
Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Catheter-directed thrombolysis; Deep venous thrombosis; Iliofemoral vein stenosis; Percutaneous mechanical thrombectomy; Stent

Year:  2019        PMID: 31327743     DOI: 10.1016/j.jvsv.2019.03.020

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  5 in total

1.  Percutaneous endovenous intervention versus anticoagulation in the treatment of lower extremity deep vein thrombosis: a systematic review and meta-analysis.

Authors:  Guofu Hu; Jian Wang
Journal:  Ann Transl Med       Date:  2022-09

2.  Clinical outcomes of AngioJet rheolytic thrombectomy in the treatment of May-Thurner syndrome-related deep venous thrombosis.

Authors:  Wen-Cheng Wei; Chun-Hsien Hsin; Hsuan-Tzu Yang; Ta-Wei Su; I-Hao Su; Sung-Yu Chu; Po-Jen Ko; Sheng-Yueh Yu; Chun-Hui Lee
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

3.  A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.

Authors:  Ghulam M Majeed; Krishan Lodhia; Jemima Carter; Jack Kingdon; Rachael I Morris; Adam Gwozdz; Athanasios Saratzis; Prakash Saha
Journal:  J Endovasc Ther       Date:  2021-11-10       Impact factor: 3.089

4.  Combined pharmacomechanical thrombectomy with selective catheter-directed thrombolysis in patients with acute proximal deep vein thrombosis.

Authors:  Mustafa Aldağ; Ufuk Çiloğlu
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2022-04-27       Impact factor: 0.704

Review 5.  [Antithrombotic therapy after iliac vein stenting].

Authors:  Wen Zhong; Yan Lou; Chenyang Qiu; Donglin Li; Hongkun Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.